- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2105
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Extracting drug-drug interactions from biomedical texts ; volume:11 ; number:5 ; day:06 ; month:10 ; year:2010 ; pages:1-2 ; date:10.2010
BMC bioinformatics ; 11, Heft 5 (06.10.2010), 1-2, 10.2010
- Urheber
-
Segura-Bedmar, Isabel
- Beteiligte Personen und Organisationen
-
Martinez, Paloma
de Pablo-Sánchez, César
SpringerLink (Online service)
- DOI
-
10.1186/1471-2105-11-S5-P9
- URN
-
urn:nbn:de:1111-2016021724470
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Segura-Bedmar, Isabel
- Martinez, Paloma
- de Pablo-Sánchez, César
- SpringerLink (Online service)
Ähnliche Objekte (12)
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
DPDDI: a deep predictor for drug-drug interactions
A Minimal Information Model for Potential Drug-Drug Interactions
Drug-drug interactions. Things to do in pain management
Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants
Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes
Data-driven prediction of adverse drug reactions induced by drug-drug interactions
Clinically relevant drug–drug interactions among elderly people with dementia
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
DPDDI: a deep predictor for drug-drug interactions
A Minimal Information Model for Potential Drug-Drug Interactions
Drug-drug interactions. Things to do in pain management
Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants
Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes
Data-driven prediction of adverse drug reactions induced by drug-drug interactions
Clinically relevant drug–drug interactions among elderly people with dementia
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
DPDDI: a deep predictor for drug-drug interactions
A Minimal Information Model for Potential Drug-Drug Interactions
Drug-drug interactions. Things to do in pain management
Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants
Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes
Data-driven prediction of adverse drug reactions induced by drug-drug interactions
Clinically relevant drug–drug interactions among elderly people with dementia